CD73 specific siRNA loaded chitosan lactate nanoparticles potentiate the antitumor effect of a dendritic cell vaccine in 4T1 breast cancer bearing mice

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Journal of Controlled Release

• Publication date

  2017-01-28

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.jconrel.2016.12.012PMID 27993599
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards

  2016cited by this paper
• Inhibition of HIF-1α enhances anti-tumor effects of dendritic cell-based vaccination in a mouse model of breast cancer

  2016cited by this paper
• Dendritic cell based immunotherapy using tumor stem cells mediates potent antitumor immune responses.

  2016cited by this paper
• Tumor-associated macrophages: Potential therapeutic targets for anti-cancer therapy.

  2016cited by this paper
• T cell receptor signalling in the control of regulatory T cell differentiation and function

  2016cited by this paper
• Downregulation of CD73 in 4T1 breast cancer cells through siRNA-loaded chitosan-lactate nanoparticles

  2016cited by this paper
• Low Noncytotoxic Concentrations of 5-Fluorouracil Have No Adverse Effects on Maturation and Function of Bone Marrow-Derived Dendritic Cells in vitro: A Potentially Safe Adjuvant for Dendritic Cell-Based Cancer Therapy

  2015cited by this paper
• The burgeoning family of unconventional T cells

  2015cited by this paper
• Technologies for controlled, local delivery of siRNA.

  2015cited by this paper
• A2a and a2b adenosine receptors affect HIF‐1α signaling in activated primary microglial cells

  2015cited by this paper
• In vitro induction of potent tumor-specific cytotoxic T lymphocytes using TLR agonist-activated AML-DC

  2014cited by this paper
• Anti‐CD73 therapy impairs tumor angiogenesis

  2014cited by this paper
• Tumor hypoxia does not drive differentiation of tumor-associated macrophages but rather fine-tunes the M2-like macrophage population.

  2014cited by this paper
• Nanocarrier mediated delivery of siRNA/miRNA in combination with chemotherapeutic agents for cancer therapy: current progress and advances.

  2014cited by this paper
• Are the anatomical sites for vaccine administration selected judiciously?

  2014cited by this paper
• Antitumor Action of a Novel Histone Deacetylase Inhibitor, YF479, in Breast Cancer

  2014cited by this paper
• Clinical trials of dendritic cell-based cancer vaccines in hematologic malignancies

  2014cited by this paper
• Regulation of Inflammation by Adenosine

  2013cited by this paper
• Downregulation of IL-17-producing T cells is associated with regulatory T cell expansion and disease progression in chronic lymphocytic leukemia

  2013cited by this paper
• Influence of tumour micro-environment heterogeneity on therapeutic response

  2013cited by this paper
• Modulation of u-PA, MMPs and their inhibitors by a novel nutrient mixture in adult human sarcoma cell lines

  2013cited by this paper
• Inhibition of CD73 Improves B Cell-Mediated Anti-Tumor Immunity in a Mouse Model of Melanoma

  2012cited by this paper
• CD73-deficient mice are resistant to carcinogenesis.

  2012cited by this paper
• CD73-deficient mice have increased antitumor immunity and are resistant to experimental metastasis.

  2011cited by this paper
• Adenosinergic Regulation of the Expansion and Immunosuppressive Activity of CD11b+Gr1+ Cells

  2011cited by this paper
• Real-time and non-invasive optical imaging of tumor-targeting glycol chitosan nanoparticles in various tumor models.

  2011cited by this paper
• Reduced efficacy of multiple doses of CpG-matured dendritic cell tumor vaccine in an experimental model.

  2011cited by this paper
• CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice.

  2011cited by this paper
• Altered purinergic signaling in CD73‐deficient mice inhibits tumor progression

  2011cited by this paper
• Dendritic Cell Based Tumor Vaccination in Prostate and Renal Cell Cancer: A Systematic Review and Meta-Analysis

  2011cited by this paper
• Anti-CD73 antibody therapy inhibits breast tumor growth and metastasis

  2010cited by this paper
• RNAi‐mediated CD73 suppression induces apoptosis and cell‐cycle arrest in human breast cancer cells

  2010cited by this paper
• CD73 on tumor cells impairs antitumor T-cell responses: a novel mechanism of tumor-induced immune suppression.

  2010cited by this paper
• Evaluation of chitosan salts as non-viral gene vectors in CHO-K1 cells.

  2008cited by this paper
• Adenosine, an endogenous distress signal, modulates tissue damage and repair

  2007cited by this paper
• RNA interference of ecto-5′-nucleotidase (CD73) inhibits human breast cancer cell growth and invasion

  2007cited by this paper
• Chitosan lactate as a nonviral gene delivery vector in COS-1 cells

  2006cited by this paper
• A2A adenosine receptor protects tumors from antitumor T cells

  2006cited by this paper
• Gs Protein-Coupled Adenosine Receptor Signaling and Lytic Function of Activated NK Cells1

  2005cited by this paper
• Influence of molecular weight on oral absorption of water soluble chitosans.

  2005cited by this paper
• Adenosine Suppresses α4β7 Integrin-Mediated Adhesion of T Lymphocytes to Colon Adenocarcinoma Cells

  2002cited by this paper
• Adenosine suppresses alpha(4)beta(7) integrin-mediated adhesion of T lymphocytes to colon adenocarcinoma cells.

  2002cited by this paper
• A(3) adenosine receptors in human neutrophils and promyelocytic HL60 cells: a pharmacological and biochemical study.

  2002cited by this paper
• Hypoxia-induced inhibition of adenosine kinase potentiates cardiac adenosine release.

  1997cited by this paper
• The extracellular fluid of solid carcinomas contains immunosuppressive concentrations of adenosine.

  1997cited by this paper
• Adenosine as a possible inhibitor of killer T‐cell activation in the microenvironment of solid tumours

  1994cited by this paper
• Adenosine, an endogenous anti-inflammatory agent.

  1994cited by this paper
• Colon adenocarcinoma cells inhibit anti-CD3-activated killer cell induction

  1994cited by this paper
• Dendritic cell progenitors phagocytose particulates, including bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo

  1993cited by this paper
• The FASEB Journal • Research Communication HIF-dependent induction of adenosine A2B receptor in hypoxia

  year unknowncited by this paper

• Advances in the combined treatment of solid tumors with nanodelivery systems based on engineered bacteria-TME modulation.

  2026cites this paper
• Adenosine receptors on the immuno-oncology expressway: TIME, perspectives, and translation

  2026cites this paper
• Ammonium metabolism rewiring in the prostate cancer microenvironment: Mechanisms and clinical prospects

  2025cites this paper
• Tumor-derived small extracellular vesicles loaded with functionally active miR-34a mimic can modify the anti-tumor response in 4T1 breast cancer animal model

  2025cites this paper
• The concurrent silencing of Tim-3 and STAT-3 promotes tumor regression both in vitro and in ovo

  2025cites this paper
• Engineered bacterial outer membrane vesicles enhanced tumor immunotherapy through remodeling tumor stroma and targeted delivery of CD73 siRNA.

  2025cites this paper
• Targeted cancer treatment using folic acid-functionalized carbohydrate polymers: A new era in nanomedicine

  2025cites this paper
• Chitosan-based materials and strategies in immunotherapy and synergistic immunochemotherapy: A focus on gene-based immunoregulation and CAR-T and adoptive cell transfer

  2025cites this paper
• Recent Advances in Cancer Immunotherapy Aided by Regulatory Non-Coding RNA: A Review

  2025cites this paper
• Therapeutic potential of adenosine receptor modulators in cancer treatment

  2025cites this paper
• Magnetic mesoporous silica nanoparticles as advanced polymeric scaffolds for efficient cancer chemotherapy: recent progress and challenges

  2025cites this paper
• Impact of Chitosan Nanoparticles-Coated Dendritic Cell-Based Vaccine as Cancer Immunotherapy

  2025cites this paper
• Control of aggressive 4T1-luc metastatic breast cancer using immunogenic cell lysates generated with methotrexate.

  2025cites this paper
• Advancing the therapeutic effectiveness of paclitaxel in chronic lymphocytic leukemia through the simultaneous inhibition of NOTCH1 and SF3B1

  2025cites this paper
• Simultaneous blockade of the CD73/EGFR axis inhibits tumor growth

  2025cites this paper
• Polydopamine-based Nanoadjuvants Promote a Positive Feedback Loop for Cancer Immunotherapy via Overcoming Photothermally Boosted T Cell Exhaustion

  2025cites this paper
• Nanotechnology-based immunotherapy, an emerging paradigm in breast cancer therapeutics.

  2025cites this paper
• Chitosan- and hyaluronic acid-based nanoarchitectures in phototherapy: Combination cancer chemotherapy, immunotherapy and gene therapy.

  2024cites this paper
• Non-Coding RNAs in Breast Cancer: Diagnostic and Therapeutic Implications

  2024cites this paper
• Leptin/LPS-treated dendritic cells reduce the expression of genes involved in tumor tissue metastasis and angiogenesis in an animal model of breast cancer

  2024cites this paper
• A review of carbohydrate polymer-synthesized nanoparticles in cancer immunotherapy: Past, present and future perspectives.

  2024cites this paper
• Chitosan-based nanoarchitectures for siRNA delivery in cancer therapy: A review of pre-clinical and clinical importance.

  2024cites this paper
• Metabolic reprogramming and therapeutic resistance in primary and metastatic breast cancer

  2024cites this paper
• Bio-mimetic strategies to re-activate apoptotic cell death for cancer treatments

  2024cites this paper
• The potential of nanosystems in disrupting adenosine signaling pathways for tumor immunotherapy

  2024cites this paper
• Recent advances on chitosan/hyaluronic acid-based stimuli-responsive hydrogels and composites for cancer treatment: A comprehensive review.

  2024cites this paper
• Treg Cell Therapeutic Strategies for Breast Cancer: Holistic to Local Aspects

  2024cites this paper
• Current Understanding of the Role of Adenosine Receptors in Cancer

  2024cites this paper
• Breast Cancer Treatment Strategies Targeting the Tumor Microenvironment: How to Convert “Cold” Tumors to “Hot” Tumors

  2024cites this paper
• Recent Advances in Immune Regulation by Targeting Dendritic Cells using Small Interfering RNAs.

  2024cites this paper
• Synergistic antitumor immune response mediated by paclitaxel-conjugated nanohybrid oncolytic adenovirus with dendritic cell therapy

  2024cites this paper
• Mathematical modeling of hypoxia and adenosine to explore tumor escape mechanisms in DC-based immunotherapy

  2024influential citation
• The Chemical Modification to Improve Solubility of Chitosan and Its Derivatives Application, Preparation Method, Toxicity as a Nanoparticles

  2024cites this paper
• Application of Nanomedicine in Tumor Targeting Inflammatory Pathway.

  2024cites this paper
• Nano-medicine therapy reprogramming metabolic network of tumour microenvironment: new opportunity for cancer therapies

  2024cites this paper
• Understanding the Interplay of CAR-NK Cells and Triple-Negative Breast Cancer: Insights from Computational Modeling

  2024cites this paper
• Immune cell membrane-based biomimetic nanomedicine for treating cancer metastasis

  2023cites this paper
• Chitosan-based bio(nano)platforms and hydrogels in breast cancer therapy: immunotherapy, phototherapy and stimuli-responsive devices.

  2023cites this paper
• Leptin/lipopolysaccharide-treated dendritic cell vaccine improved cellular immune responses in an animal model of breast cancer

  2023cites this paper
• Sialic Acid Engineered Prodrug Nanoparticles for Codelivery of Bortezomib and Selenium in Tumor Bearing Mice.

  2023cites this paper
• Peptide-Based Vaccine against Breast Cancer: Recent Advances and Prospects

  2023cites this paper
• Functionalized chitosan for cancer nano drug delivery.

  2023cites this paper
• The Antitumor Effect of Topotecan Loaded Thiolated Chitosan-Dextran Nanoparticles for Intravitreal Chemotherapy: A Xenograft Retinoblastoma Model

  2023cites this paper
• (Nano)platforms in breast cancer therapy: Drug/gene delivery, advanced nanocarriers and immunotherapy

  2023cites this paper
• Current and emerging applications of saccharide-modified chitosan: a critical review.

  2023cites this paper
• CD73 mediated host purinergic metabolism in intestine contributes to the therapeutic efficacy of a novel mesenchymal-like endometrial regenerative cells against experimental colitis

  2023cites this paper
• Positron emission tomography imaging sheds new light on hypoxia and antitumor therapies

  2023cites this paper
• Vaccination with celecoxib-treated dendritic cells improved cellular immune responses in an animal breast cancer model.

  2023cites this paper
• Inhibition of apelin/APJ axis enhances the potential of dendritic cell-based vaccination to modulate TH1 and TH2 cell-related immune responses in an animal model of metastatic breast cancer.

  2022cites this paper
• Functional polymeric core–shell hybrid nanoparticles overcome intestinal barriers and inhibit breast cancer metastasis

  2022cites this paper
• CD73 downregulation by EGFR-targeted liposomal CD73 siRNA potentiates antitumor effect of liposomal doxorubicin in 4T1 tumor-bearing mice

  2022cites this paper
• Co-delivery of siRNA and lycopene encapsulated hybrid lipid nanoparticles for dual silencing of insulin-like growth factor 1 receptor in MCF-7 breast cancer cell line.

  2022cites this paper
• The Microstructure, Antibacterial and Antitumor Activities of Chitosan Oligosaccharides and Derivatives

  2022cites this paper
• Synergistic effect of avidin/biotin system with biofunctionalized graphene oxide based nanocarrier in targeted co‐delivery of hydrophobic anticancer drug SN‐38

  2022cites this paper
• Combination Cancer Immunotherapy with Dendritic Cell Vaccine and Nanoparticles Loaded with Interleukin-15 and Anti-beta-catenin siRNA Significantly Inhibits Cancer Growth and Induces Anti-Tumor Immune Response

  2022cites this paper
• Nano-immunotherapeutics: targeting approach as strategic regulation at tumor microenvironment for cancer treatment

  2022cites this paper
• Nanomedicine as a Promising Tool to Overcome Immune Escape in Breast Cancer

  2022cites this paper
• Functionalized chitosan as a promising platform for cancer immunotherapy: A review.

  2022cites this paper
• Tumor-associated macrophages: Potential target of natural compounds for management of breast cancer.

  2022cites this paper
• Potent anti-tumor immune response and tumor growth inhibition induced by HER2 subdomain fusion protein in a mouse tumor model

  2022cites this paper
• Nanodelivery Systems Delivering Hypoxia-Inducible Factor-1 Alpha Short Interfering RNA and Antisense Oligonucleotide for Cancer Treatment

  2022cites this paper
• Breast cancer vaccines: New insights into immunomodulatory and nano-therapeutic approaches.

  2022cites this paper
• Immune Checkpoint Inhibitors for Vaccine Improvements: Current Status and New Approaches

  2022cites this paper
• Combined inhibition of EZH2 and CD73 molecules by folic acid-conjugated SPION-TMC nanocarriers loaded with siRNA molecules prevents TNBC progression and restores anti-tumor responses.

  2022cites this paper
• Nanobiotherapeutic strategies to target immune microenvironment of triple-negative breast cancer.

  2022cites this paper
• Increased susceptibility to doxorubicin-induced cell death in acute lymphocytic leukemia cells by inhibiting serine/threonine WEE1 kinase expression using the chitosan-carboxymethyl dextran-polyethylene glycol-TAT nanoparticles

  2022cites this paper
• Immunosuppressive adenosine-targeted biomaterials for emerging cancer immunotherapy

  2022cites this paper
• Inhibitory effects of postbiotic consisting sonication-killed Bifidobacterium bifidum on experimental triple negative breast neoplasm in mice: a preliminary study

  2022cites this paper
• N-2-Hydroxypropylmethacrylamide-Polycaprolactone Polymeric Micelles in Co-delivery of Proteasome Inhibitor and Polyphenol: Exploration of Synergism or Antagonism.

  2022cites this paper
• The effects of dendritic cell-based vaccines in the tumor microenvironment: Impact on myeloid-derived suppressor cells

  2022cites this paper
• Formulation of Lipid-Based Nanoparticles for Simultaneous Delivery of Lapatinib and Anti-Survivin siRNA for HER2+ Breast Cancer Treatment

  2022cites this paper
• Preclinical Assessment of Immunogenicity and Protectivity of Novel ROR1 Fusion Proteins in a Mouse Tumor Model

  2022cites this paper
• Nanoscience versus Viruses: The SARS‐CoV‐2 Case

  2021cites this paper
• Effect of cell free supernatant of Bifidobacterium bifidum combined with chitosan biodegradable film on full thickness wound healing in rats

  2021cites this paper
• Nanomedicine-based cancer immunotherapy: recent trends and future perspectives

  2021cites this paper
• Hypoxia-modulatory nanomaterials to relieve tumor hypoxic microenvironment and enhance immunotherapy: where do we stand?

  2021cites this paper
• Blockade of HIF-1α and STAT3 by hyaluronate-conjugated TAT-chitosan-SPION nanoparticles loaded with siRNA molecules prevents tumor growth.

  2021cites this paper
• Biomedical application of chitosan-based nanoscale delivery systems: Potential usefulness in siRNA delivery for cancer therapy.

  2021cites this paper
• Silencing STAT3 enhances sensitivity of cancer cells to doxorubicin and inhibits tumor progression.

  2021cites this paper
• Simultaneous inhibition of CD73 and IL-6 molecules by siRNA-loaded nanoparticles prevents the growth and spread of Cancer.

  2021cites this paper
• Nano-delivery systems focused on tumor microenvironment regulation and biomimetic strategies for treatment of breast cancer metastasis.

  2021cites this paper
• Immunomodulatory potential of chitosan-based materials for cancer therapy: a systematic review of in vitro, in vivo and clinical studies.

  2021cites this paper
• Myeloid-Derived Suppressor Cells: Implications in the Resistance of Malignant Tumors to T Cell-Based Immunotherapy

  2021cites this paper
• Advances in Engineered Polymer Nanoparticle Tracking Platforms towards Cancer Immunotherapy—Current Status and Future Perspectives

  2021cites this paper
• Modeling codelivery of CD73 inhibitor and dendritic cell-based vaccines in cancer immunotherapy

  2021cites this paper
• Recent advances in breast cancer immunotherapy: The promising impact of nanomedicines.

  2021cites this paper
• Chitosan-based polyelectrolyte complexes in biomedical applications

  2021cites this paper
• Disruption of adenosine 2A receptor improves the anti-tumor function of anti-mesothelin CAR T cells both in vitro and in vivo.

  2021cites this paper
• Simultaneous blockade of TIGIT and HIF-1α induces synergistic anti-tumor effect and decreases the growth and development of cancer cells.

  2021cites this paper
• The role of regulatory T cells in the pathogenesis and treatment of prostate cancer.

  2021cites this paper
• Preventive effects of microvesicles isolated from Bifidobacterium bifidum on 4T1-induced breast cancer in BALB/c mice

  2021cites this paper
• An overview of current therapeutic strategies for glioblastoma and the role of CD73 as an alternative curative approach

  2021cites this paper
• Targeting hypoxia and hypoxia‐inducible factor‐1 in the tumor microenvironment for optimal cancer immunotherapy

  2021cites this paper
• Simultaneous silencing of A2aR and PD-1 as immune checkpoints by siRNA-loaded nanoparticles enhances the immunotherapeutic potential of dendritic cell vaccine in tumor experimental models.

  2021cites this paper
• Application of chitosan modified nanocarriers in breast cancer.

  2021cites this paper
• Silencing tumor-intrinsic CD73 enhances the chemosensitivity of NSCLC and potentiates the anti-tumoral effects of cisplatin: An in vitro study.

  2021cites this paper
• Chitosan: A versatile bio-platform for breast cancer theranostics.

  2021cites this paper
• Polymeric nanoparticle vaccines to combat emerging and pandemic threats

  2020cites this paper
• Current Perspectives, Challenges and Advances in Cell Based Therapies

  2020cites this paper
• Optimized Dose of Dendritic Cell-based Vaccination in Experimental Model of Tumor Using Artificial Neural Network.

  2020cites this paper